Hideki Ishihara
R&D Department, 1, Shiojima, Fukuhara, Fukuyama
Koriyama, 9638091, Japan
Koriyama, 9638091, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
The utility of smartphone-based quantitative analysis of SARS-CoV-2-specific antibody lateral flow assays.
Journal: Diagnostic microbiology and infectious disease
Published: September 12, 2023
MEK and PI3K catalytic activity as predictor of the response to molecularly targeted agents in triple-negative breast cancer.
Journal: Biochemical and biophysical research communications
Published: May 17, 2017
Sandwich ELISA Using a Mouse/Human Chimeric CSLEX-1 Antibody.
Journal: Clinical chemistry
Published: May 17, 2016
Prognostic importance of CDK4/6-specific activity as a predictive marker for recurrence in patients with endometrial cancer, with or without adjuvant chemotherapy.
Journal: British journal of cancer
Published: July 09, 2015
Cyclin-Dependent Kinase Activity Correlates with the Prognosis of Patients Who Have Gastrointestinal Stromal Tumors.
Journal: Annals of surgical oncology
Published: December 28, 2014
CDK1 and CDK2 activity is a strong predictor of renal cell carcinoma recurrence.
Journal: Urologic oncology
Published: March 19, 2014
The prognostic value of apoptotic and proliferative markers in breast cancer.
Journal: Breast cancer research and treatment
Published: September 03, 2013
Novel functional assay for spindle-assembly checkpoint by cyclin-dependent kinase activity to predict taxane chemosensitivity in breast tumor patient.
Journal: Journal of Cancer
Published: March 15, 2013
Last Updated: 09/26/2026